Your browser doesn't support javascript.
loading
[Hematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Prise en charge des complications ophtalmologiques de l'allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Borel, Cécile; Ahmad, Imran; Ceballos, Patrice; Desbrosses, Yohann; Hamzy, Fati; Ravinet, Aurélie; Souchet, Laetitia; Turlure, Pascal; Villate, Alban; Yakoub-Agha, Ibrahim; Guillaume, Thierry.
Afiliação
  • Borel C; Institut universitaire du cancer de Toulouse, service d'hématologie, 1, avenue Irène Joliot-Curie, 31100 Toulouse, France. Electronic address: borel.cecile@iuct-oncopole.fr.
  • Ahmad I; Hôpital maisonneuve - Rosemont, service d'hématologie et oncologie médicale, 5415, boulevard de l'Assomption, H1T2M4 Montréal, QC, Canada.
  • Ceballos P; CHU de Saint-Éloi, UGH hématologie, 80, avenue Augustin-Fliche, 34080 Montpellier, France.
  • Desbrosses Y; CHRU Jean-Minjoz Besançon, service d'hématologie, 3, boulevard Flemming, 25030 Besançon cedex, France.
  • Hamzy F; Hôpital Cheikh Zaïd universitaire international, service d'hématologie et greffe, Cite al Irfane - Hay Ryad avenue Allal al Fassi, 6533 Rabat, Maroc.
  • Ravinet A; Université d'Auvergne, CHU d'Estaing, service d'hématologie, 1, place Lucie-Aubrac, 63000 Clermont-Ferrand, France.
  • Souchet L; Centre hospitalier de La Pitié-Salpetrière, service d'hématologie, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
  • Turlure P; CHU de Dupuytren Limoges, service d'hématologie, 2, avenue Martin Luther-King, 87000 Limoges, France.
  • Villate A; CHU de Bretonneau Tours, service d'hématologie et thérapie cellulaire, 2, boulevard Tonnelé, 37044 Tours cedex 9, France.
  • Yakoub-Agha I; Université Lille, CHU de Lille, Inserm, Infinite, U1286, 59000 Lille, France.
  • Guillaume T; CHU de Nantes, service d'hématologie, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Bull Cancer ; 107(12S): S116-S121, 2020 Dec.
Article em Fr | MEDLINE | ID: mdl-32631612
ABSTRACT

INTRODUCTION:

Allogeneic stem cell transplantation is currently the only curative therapy for hematological disorders. This treatment can lead to complications, of which ophtalmological involvement.

METHODS:

We reviewed the literature and established accessible and convenient recommendations for hematologists and ophthalmologists.

RESULTS:

Ophtalmological follow-up should be done in every patient having had an allogeneic transplantation, by the hematologist questioning and by the ophthalmologist physical exam. Complications due to graft-versus-host disease (GVHD) or not due to GVHD are cited, as well as therapeutic options.

DISCUSSION:

Screening and treatment of ophthalmologic complications in allogeneic stem cells transplantation recipients requires a close collaboration between hematologists and ophthalmologists. The management of these patients by caregivers trained in these questions is encouraged.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Oftalmopatias Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Oftalmopatias Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2020 Tipo de documento: Article